TP53 and cancer: By using Li–Fraumeni syndrome- (LFS; a rare inherited genetic disorder with germline TP53 mutation) derived induced pluripotent stem cells (iPSCs) (72–74), they observed aberrant proliferation and anchorage-independent growth in LFS-derived astrocytes and organoids, which are hallmark features of cancer.